novo nordisk's wegovy reduces cardiovascular risk more than lilly's tirzepatide Weight-Loss Drug Lowers Major Heart Disease By 20%, Trial Says—Novo Nordisk Shares Surge Semaglutide may reduce heart events

Here is what the typical progression looks like: Week 1 to 2: Initial onset

Aim for at least 64 ounces daily, more if you are physically active or in a warm climate

Injectable Semaglutide Both injectable and sublingual semaglutide have demonstrated efficacy in aiding weight loss and improving glycemic control in individuals with type 2 diabetes

Heart benefits may extend beyond losing more weight The findings suggest that the cardiovascular benefits associated with semaglutide may not be fully explained by the amount of weight patients lose while taking the drug

OTC medications that contain simethicone, such as Mylanta and Gas-X, treat flatulence and relieve bloating, another common side effect of semaglutide

Injection anxiety that builds throughout the day can be more harmful than any pharmacological timing consideration